Joshi A - Search Results

1

Comparative Efficacy of Targeted Systemic Therapies for Moderate to Severe Atopic Dermatitis without Topical Corticosteroids: Systematic Review and Network Meta-analysis.

Silverberg JI, Hong HC, Thyssen JP, Calimlim BM, Joshi A, Teixeira HD, Collins EB, Crowell MM, Johnson SJ, Armstrong AW. Silverberg JI, et al. Among authors: joshi a. Dermatol Ther (Heidelb). 2022 May;12(5):1181-1196. doi: 10.1007/s13555-022-00721-1. Epub 2022 Apr 18. Dermatol Ther (Heidelb). 2022. PMID: 35435637 Free PMC article.

2

Comparison of Biologics and Oral Treatments for Plaque Psoriasis: A Meta-analysis.

Armstrong AW, Puig L, Joshi A, Skup M, Williams D, Li J, Betts KA, Augustin M. Armstrong AW, et al. Among authors: joshi a. JAMA Dermatol. 2020 Mar 1;156(3):258-269. doi: 10.1001/jamadermatol.2019.4029. JAMA Dermatol. 2020. PMID: 32022825 Free PMC article.

3

Comparative safety and benefit-risk profile of biologics and oral treatment for moderate-to-severe plaque psoriasis: A network meta-analysis of clinical trial data.

Shear NH, Betts KA, Soliman AM, Joshi A, Wang Y, Zhao J, Gisondi P, Sinvhal R, Armstrong AW. Shear NH, et al. Among authors: joshi a. J Am Acad Dermatol. 2021 Sep;85(3):572-581. doi: 10.1016/j.jaad.2021.02.057. Epub 2021 Feb 22. J Am Acad Dermatol. 2021. PMID: 33631216 Free article.

4

Network Meta-Analysis and Cost Per Responder of Tumor Necrosis Factor-α and Interleukin Inhibitors in the Treatment of Active Ankylosing Spondylitis.

Betts KA, Griffith J, Song Y, Mittal M, Joshi A, Wu EQ, Ganguli A. Betts KA, et al. Among authors: joshi a. Rheumatol Ther. 2016 Dec;3(2):323-336. doi: 10.1007/s40744-016-0038-y. Epub 2016 Jul 25. Rheumatol Ther. 2016. PMID: 27747581 Free PMC article.

5

Effect of Risankizumab on Patient-Reported Outcomes in Moderate to Severe Psoriasis: The UltIMMa-1 and UltIMMa-2 Randomized Clinical Trials.

Augustin M, Lambert J, Zema C, Thompson EHZ, Yang M, Wu EQ, Garcia-Horton V, Geng Z, Valdes JM, Joshi A, Gordon KB. Augustin M, et al. Among authors: joshi a. JAMA Dermatol. 2020 Dec 1;156(12):1344-1353. doi: 10.1001/jamadermatol.2020.3617. JAMA Dermatol. 2020. PMID: 33052382 Free PMC article. Clinical Trial.

6

Comparative Effectiveness of Adalimumab versus Secukinumab for the Treatment of Psoriatic Arthritis: A Matching-Adjusted Indirect Comparison.

Strand V, Betts KA, Mittal M, Song J, Skup M, Joshi A. Strand V, et al. Among authors: joshi a. Rheumatol Ther. 2017 Dec;4(2):349-362. doi: 10.1007/s40744-017-0070-6. Epub 2017 Jul 31. Rheumatol Ther. 2017. PMID: 28762213 Free PMC article.

7

The impact of achieving and maintaining near-complete or complete skin clearance on patient quality of life in moderate-to-severe psoriasis.

Ryan C, Puig L, Zema C, Thompson EHZ, Yang M, Wu E, Bensimon A, Huang X, Joshi AD, Elewski B. Ryan C, et al. Among authors: joshi ad. J Am Acad Dermatol. 2023 Jan;88(1):169-172. doi: 10.1016/j.jaad.2021.12.032. Epub 2021 Dec 24. J Am Acad Dermatol. 2023. PMID: 34954285 No abstract available.

8

An economic evaluation of risankizumab versus other biologic treatments of moderate to severe plaque psoriasis in Japan.

Saeki H, Ishii K, Joshi A, Bensimon AG, Yang H, Kawaguchi I. Saeki H, et al. Among authors: joshi a. J Dermatolog Treat. 2022 Feb;33(1):229-239. doi: 10.1080/09546634.2020.1744505. Epub 2020 Apr 17. J Dermatolog Treat. 2022. PMID: 32178555 Free article.

9

ASAS40 and ASDAS clinical responses in the ABILITY-1 clinical trial translate to meaningful improvements in physical function, health-related quality of life and work productivity in patients with non-radiographic axial spondyloarthritis.

van der Heijde D, Joshi A, Pangan AL, Chen N, Betts K, Mittal M, Bao Y. van der Heijde D, et al. Among authors: joshi a. Rheumatology (Oxford). 2016 Jan;55(1):80-8. doi: 10.1093/rheumatology/kev267. Epub 2015 Aug 27. Rheumatology (Oxford). 2016. PMID: 26316575 Free PMC article. Clinical Trial.

10

Corticosteroid-Related Adverse Events Systematically Increase with Corticosteroid Dose in Noninfectious Intermediate, Posterior, or Panuveitis: Post Hoc Analyses from the VISUAL-1 and VISUAL-2 Trials.

Suhler EB, Thorne JE, Mittal M, Betts KA, Tari S, Camez A, Bao Y, Joshi A. Suhler EB, et al. Among authors: joshi a. Ophthalmology. 2017 Dec;124(12):1799-1807. doi: 10.1016/j.ophtha.2017.06.017. Epub 2017 Jul 6. Ophthalmology. 2017. PMID: 28689898 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,702 results

Search Page

Filters